Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
This week is going to be a bit zany with travel. That’s going to wreak havoc on the Cost Curve publishing timetable. Please bear with me, because I suspect there
Yesterday, feeling snarky, I asked a rhetorical question: “What has United done for anyone lately?” The point, in the context of yet another set of record profits for UnitedHealth Group,